Proglumide has a broad safety profile, and has been shown to decrease tissue inflammation, lower transaminases in hepatitis [65], and decrease pancreatitis as demonstrated by lowering serum lipase and C-reactive protein levels [66]. Here, CRP is linked to hepatitis A virus infection.